Ascendis Pharma A/S (ASND) Short Interest Ratio & Short Volume → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free ASND Stock Alerts $151.17 +2.73 (+1.84%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Ascendis Pharma A/S Short Interest DataCurrent Short Volume2,940,000 sharesPrevious Short Volume3,000,000 sharesChange Vs. Previous Month-2.00%Dollar Volume Sold Short$437.18 millionShort Interest Ratio / Days to Cover7.5Last Record DateMarch 15, 2024Outstanding Shares57,710,000 sharesPercentage of Shares Shorted5.09%Today's Trading Volume295,863 sharesAverage Trading Volume295,281 sharesToday's Volume Vs. Average100% Short Selling Ascendis Pharma A/S ? Sign up to receive the latest short interest report for Ascendis Pharma A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatASND Short Interest Over TimeASND Days to Cover Over TimeASND Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Ascendis Pharma A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20242,940,000 shares $437.18 million -2.0%N/A7.5 $148.70 2/29/20243,000,000 shares $443.28 million +1.0%N/A5.7 $147.76 2/15/20242,970,000 shares $437.18 million +1.4%N/A5.2 $147.20 1/31/20242,930,000 shares $380.69 million -9.9%N/A5.2 $129.93 1/15/20243,250,000 shares $426.50 million -4.7%N/A5.8 $131.23 12/31/20233,410,000 shares $429.49 million -17.8%N/A6 $125.95 Get the Latest News and Ratings for ASND and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. 12/15/20234,150,000 shares $502.03 million -19.7%N/A7.4 $120.97 11/30/20235,170,000 shares $519.22 million +3.6%N/A10.9 $100.43 11/15/20234,990,000 shares $463.92 million -9.8%N/A13.1 $92.97 10/31/20235,530,000 shares $493.88 million +22.9%N/A15.4 $89.31 10/15/20234,500,000 shares $421.07 million +9.8%N/A13.3 $93.57 9/30/20234,100,000 shares $383.92 million +1.0%N/A14.9 $93.64 9/15/20234,060,000 shares $416.80 million -10.6%N/A15.2 $102.66 8/31/20234,540,000 shares $445.01 million -5.0%N/A18 $98.02 8/15/20234,780,000 shares $442.15 million +6.0%N/A20.2 $92.50 7/31/20234,510,000 shares $406.58 million +6.9%N/A15.8 $90.15 7/15/20234,220,000 shares $365.16 million +3.4%N/A8.5 $86.53 6/30/20234,080,000 shares $364.14 million +0.7%N/A7 $89.25 6/15/20234,050,000 shares $374.46 million +3.1%N/A5 $92.46 5/31/20233,930,000 shares $341.79 million -11.3%N/A4.9 $86.97 5/15/20234,430,000 shares $427.89 million +13.6%N/A5.5 $96.59 4/30/20233,900,000 shares $272.84 million -21.2%N/A5 $69.96 4/15/20234,950,000 shares $401.79 million +51.8%N/A9 $81.17 3/31/20233,260,000 shares $349.54 million -0.3%N/A6.2 $107.22 3/15/20233,270,000 shares $354.86 million -0.3%N/A12.6 $108.52 2/28/20233,280,000 shares $364.38 million -1.2%N/A8.9 $111.09 2/15/20233,320,000 shares $371.84 million +5.1%N/A8.7 $112.00 1/31/20233,160,000 shares $392.09 million +1.6%N/A7.2 $124.08 1/15/20233,110,000 shares $357.74 million -61.3%N/A6.4 $115.03 12/30/20228,030,000 shares $980.70 million -1.8%N/A16.5 $122.13 12/15/20228,180,000 shares $973.50 million -14.6%N/A15.9 $119.01 11/30/20229,580,000 shares $1.18 billion -1.8%N/A18.9 $123.06 11/15/20229,760,000 shares $1.08 billion -4.7%N/A21.1 $110.15 10/31/202210,240,000 shares $1.18 billion +12.9%N/A22.2 $115.00 10/15/20229,070,000 shares $973.48 million -3.8%N/A20 $107.33 9/30/20229,430,000 shares $973.74 million +11.2%N/A20.3 $103.26 9/15/20228,480,000 shares $926.78 million +6.4%N/A19.6 $109.29 8/31/20227,970,000 shares $713.87 million +6.3%N/A19.7 $89.57 8/15/20227,500,000 shares $807.45 million +27.8%N/A18 $107.66 7/31/20225,870,000 shares $502.06 million -14.6%N/A12 $85.53Central Banks Preparing for US Dollar Collapse? (Ad)China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> ASND Short Interest - Frequently Asked Questions What is Ascendis Pharma A/S's current short interest? Short interest is the volume of Ascendis Pharma A/S shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 2,940,000 shares of ASND short. Learn More on Ascendis Pharma A/S's current short interest. What is a good short interest ratio for Ascendis Pharma A/S? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ASND shares currently have a short interest ratio of 8.0. Learn More on Ascendis Pharma A/S's short interest ratio. Which institutional investors are shorting Ascendis Pharma A/S? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ascendis Pharma A/S: GTS Securities LLC, Barclays PLC, Citadel Advisors LLC, PEAK6 Investments LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Ascendis Pharma A/S's short interest increasing or decreasing? Ascendis Pharma A/S saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 2,940,000 shares, a decrease of 2.0% from the previous total of 3,000,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ascendis Pharma A/S's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ascendis Pharma A/S: Roivant Sciences Ltd. (6.55%), Viking Therapeutics, Inc. (11.09%), Legend Biotech Co. (6.37%), Elanco Animal Health Incorporated (2.63%), Cerevel Therapeutics Holdings, Inc. (8.00%), Jazz Pharmaceuticals plc (4.60%), Cytokinetics, Incorporated (14.91%), Catalent, Inc. (4.34%), Apellis Pharmaceuticals, Inc. (8.78%), Intra-Cellular Therapies, Inc. (3.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Ascendis Pharma A/S stock? Short selling ASND is an investing strategy that aims to generate trading profit from Ascendis Pharma A/S as its price is falling. ASND shares are trading up $2.73 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ascendis Pharma A/S? A short squeeze for Ascendis Pharma A/S occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ASND, which in turn drives the price of the stock up even further. How often is Ascendis Pharma A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASND, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ROIV Short Interest VKTX Short Interest LEGN Short Interest ELAN Short Interest CERE Short Interest JAZZ Short Interest CYTK Short Interest CTLT Short Interest APLS Short Interest ITCI Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ASND) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company